Device Trial Radar · NCT07027267
Safety and Effectiveness of TurbAlign™ for Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery
Last checked: Nov 19, 2026Latest source record: Apr 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
50
Actual
Start
Aug 4, 2025
Primary completion
May 5, 2026
Study completion Jul 31, 2026
Sponsor
- Lead sponsor
- Spirair, IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 18, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study of a bioabsorbable implant to separate the middle turbinate from the lateral nasal wall associated with nasal/sinus surgery
Conditions
- Sinus Endoscopic Surgery
- Turbinate
Interventions
Implantation of Spirair device into the middle turbinatesDevice
The Spirair implant is designed to separate the middle turbinate from the lateral nasal wall during the healing phase associated with nasal/sinus surgery.
TurbAlignDevice
The Spirair implant is designed to separate the middle turbinate from the lateral nasal wall during the healing phase associated with nasal/sinus surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Miller Synechia ScoreTime frame: 8 Weeks
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Northwest Community Hospital
Arlington Heights, Illinois
Rush University Medical Center
Chicago, Illinois
Tandem Clinical Research
Marrero, Louisiana
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.